Collegium Expands Commercial Organization With Key Appointments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads gains as SpaceX, Super Micro results improve AI appetite
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Alphabet shares drop ahead of earnings next week
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Flutter Entertainment to cut up to 1,400 jobs amid UK tax increases
Collegium Pharma (COLL) Appoints New Chief Commercial Officer and Two New VPs
June 1, 2015 7:18 AM EDTCollegium Pharma (NASDAQ: COLL) announced the addition of Barry Duke as Executive Vice President and Chief Commercial Officer. In addition to Mr. Duke, Mary Ogle joined as Vice President of Marketing and Timothy Hermes as Vice President of Government Affairs and Alliance Development.
"Barry's deep experience, in both small and large organizations make him a great fit to lead our commercial organization as we prepare for FDA approval and launch of Xtampza ER." said... More



